PerkinElmer and the European Molecular Biology Laboratory (EMBL) Announce Corporate Partnership to Support EMBL Advanced Training Centre

Collaboration to support advancement of molecular biology excellence, training, research and events in Europe

WALTHAM, Mass.–PerkinElmer, Inc., a global leader in life science research, drug discovery and cellular science, and the European Molecular Biology Laboratory (EMBL) today announced that they have entered into a corporate partnership in support of the EMBL’s Advanced Training Centre in Heidelberg, Germany.

Under the terms of the partnership, PerkinElmer will sponsor and have access to the Advanced Training Centre’s center of excellence for molecular biology training in Europe, including scientific training programs, facilities, conferences and events. PerkinElmer will also provide advice regarding future conferences and programs at the Centre.

The recently established EMBL Corporate Partnership Program is designed to create and enhance long-term, effective relationships between EMBL and top-tier corporate partners.

Professor Iain Mattaj, EMBL director general, said, “Our organization is delighted to have a partner of PerkinElmer’s caliber in promoting the mission of EMBL and supporting the aims of the Advanced Training Centre. This partnership is a significant milestone in our shared vision to create a central platform for training and exchange in molecular biology in Europe. We look forward to inaugurating the state-of-the-art Centre when it is completed in 2009.”

Richard M. Eglen, Ph.D., president, Bio-discovery, PerkinElmer, said, “PerkinElmer is glad to participate in advancing one of the most active advanced training and conference centers in Europe for molecular and cellular sciences. International collaborations will be the key to future successes and breakthroughs in the field, and our work with EMBL toward this end is a very welcome step in this direction.”

< | >